1 Answers
The Drug Addiction Treatment Act of 2000 , Title XXXV, Section 3502 of the Children's Health Act, permits physicians who meet certain qualifications to treat opioid addiction with Schedule III, IV, and V narcotic medications that have been specifically approved by the Food and Drug Administration for that indication.
Since there is only one narcotic medication approved by the FDA for the treatment of opioid use disorder within the schedules given, DATA 2000 essentially governs the prescription of buprenorphine for the treatment of opioid use disorder. Methadone and LAAM are Schedule II narcotics approved for the same purpose within the highly regulated methadone clinic setting, usually known as an opioid treatment program.